
Our team possesses vast experience in respiratory diseases, having successfully completed numerous projects that enhance drug development and ensure efficiency in delivery timelines.
Committed to excellence, we adhere to strict quality procedures and GLP principles, ensuring reliable and reproducible results in all phases of preclinical research.
We offer tailored services to address specific requirements for respiratory disease studies, providing you with flexibility and focused support throughout your project lifecycle.
With a vast network of collaborations, we can facilitate partnerships and access to broader resources in drug development for respiratory diseases, enhancing project outcomes.





Comprehensive preclinical drug development and service platform
Building A2, No, 8 Yanghua road, Suzhou industrial Park, Suzhou.P.R, china